Brain+ AS (OCSE:BRAINP) Capital Expenditure : kr-4.18 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Brain+ AS Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Brain+ AS's cash flow for capital expenditures for the six months ended in Dec. 2024 was kr-2.13 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2024 was kr-4.18 Mil.

Brain+ AS Capital Expenditure Historical Data

The historical data trend for Brain+ AS's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain+ AS Capital Expenditure Chart

Brain+ AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Capital Expenditure

Get a 7-Day Free Trial

-7.00

-7.36

-5.02

-3.51

-4.18

Brain+ AS Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Capital Expenditure	Get a 7-Day Free Trial					-2.22	-2.32	-1.20	-2.05	-2.13

Brain+ AS Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-4.18 Mil.

Brain+ AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brain+ AS (OCSE:BRAINP) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

Svanevej 22, Copenhagen, DNK, 2400

Website

https://www.brain-plus.com

Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).

Brain+ AS Headlines

No Headlines